Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, April 25 2014 5:16am ET - U.S. Markets open in 4 hours and 14 minutes.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drugs - Generic News
Latest News
Friday, Apr 25, 2014
·Mallinckrodt (MNK) Jumps: Stock Rises 5.1%
Zacks.com - 2 hours, 58 minutes ago
Thursday, Apr 24, 2014
·Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against CannaVEST Corp. -- CANV
GlobeNewswire - Thu 7:00 pm ET
·[$$] Actavis Settles Celebrex Case With Pfizer
at The Wall Street Journal Online - Thu 11:03 am ET
·Paulson action positive for Mallinckrodt, Questcor, says BMO Capital
- Thu 10:58 am ET
·The Medicines Co.'s Q1 Earnings Surpass Expectations
Zacks.com - Thu 10:40 am ET
·Actavis Announces Celebrex┬« Patent Challenge Settlement
PR Newswire - Thu 9:20 am ET
·Insys Therapeutics: Finding No Pain In This Specialty Pharmaceutical Company
at Seeking Alpha - Thu 8:54 am ET
·Health Enhancement Products Announces Commencement of Bovine Mastitis Testing With Contract Research Organization Dairy Experts
Marketwire - Thu 8:23 am ET
·Karyopharm initiates Phase 2 study of Selinexor
- Thu 7:45 am ET
·MYOS Corporation Teams Up With NFL Alumni in Optimal Bowl and Wellness Challenge
Marketwire - Thu 7:35 am ET
·Salix Pharmaceuticals Announces 1Q2014 Financial Results Conference Call and Webcast
Business Wire - Thu 7:00 am ET
·Phase 2 Study of Selinexor (KPT-330) Initiated by Karyopharm in Patients With Advanced Gynecologic Malignancies (SIGN Study)
GlobeNewswire - Thu 7:00 am ET
Wednesday, Apr 23, 2014
·EQUITY ALERT: The Rosen Law Firm Files Securities Fraud Class Action Against CannaVEST Corp. -- CANV
GlobeNewswire - Wed 11:00 pm ET
·Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Marketwire - Wed 4:35 pm ET
·Nature's Sunshine Products to Announce First Quarter 2014 Financial Results and to Host Conference Call on Wednesday, May 7th
GlobeNewswire - Wed 4:05 pm ET
·Adamas Pharmaceuticals Announces Data Update At American Academy Of Neurology Annual Meeting
PR Newswire - Wed 4:00 pm ET
·The Medicines Company's CEO Discusses Q1 2014 Results - Earnings Call Transcript
- Wed 1:00 pm ET
·[$$] Is Lilly Going to the Dogs?
at Barrons.com - Wed 12:24 pm ET
·Nature's Sunshine Products' Patent-Pending AnxiousLess Formula Indicates Success of New Product Development Strategy
GlobeNewswire - Wed 9:01 am ET
·Catalyst Announces Initiation of an Expanded Access Program to Provide Firdapse at No Cost to U.S. Patients with Lambert-Eaton Myasthenic Syndrome
Business Wire - Wed 8:03 am ET
More Latest News...
Sponsor Results
Professional Statistician
1-on-1 Collaboration for your Project, Research, or Dissertation
www.OmegaStatistics.com
Paperless Reg Docs
Secure online portal for clinical study start-up.
www.ePharmaSolutions.com
Purdue Research Trials
HCPs: Join a Team of Research Experts. Sign Up to Learn More.
www.PurduePharma.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?